Evidence map›Paper›PMID 39592595›Full record

ArticleNature communications2024

Reaction blueprints and logical control flow for parallelized chiral synthesis in the Chemputer.

Mindaugas Šiaučiulis, Christian Knittl-Frank, S Hessam M Mehr, Emma Clarke, Leroy Cronin

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Chemputer and chemputation-A universal chemical compound synthesis machine.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Programmable Microwaveable Chemistry in the Chemputer.Angewandte Chemie (International ed. in English) · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mindaugas ŠiaučiulisAdvanced Research Centre, University of Glasgow, 11 Chapel Lane, Glasgow, UK.ORCID http://orcid.org/0000-0001-5252-2933
Christian Knittl-FrankAdvanced Research Centre, University of Glasgow, 11 Chapel Lane, Glasgow, UK.ORCID http://orcid.org/0000-0001-9167-5414
S Hessam M MehrAdvanced Research Centre, University of Glasgow, 11 Chapel Lane, Glasgow, UK.ORCID http://orcid.org/0000-0001-7710-3102
Emma ClarkeAdvanced Research Centre, University of Glasgow, 11 Chapel Lane, Glasgow, UK.
Leroy CroninAdvanced Research Centre, University of Glasgow, 11 Chapel Lane, Glasgow, UK. lee.cronin@glasgow.ac.uk.ORCID http://orcid.org/0000-0001-8035-5757

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) MolTag W1232EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 670467 SMART-POMRCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/L023652/1, EP/R01308X/1, EP/S019472/1, and EP/P00153X/1
6 · The paper itself

Abstract

Despite recent proliferation of programmable robotic chemistry hardware, current chemical programming ontologies lack essential structured programming constructs like variables, functions, and loops. Herein we present an integration of these concepts into χDL, a universal high-level chemical programming language executable in the Chemputer. To achieve this, we introduce reaction blueprints as a chemical analog to functions in computer science, allowing to apply sets of synthesis operations to different reagents and conditions. We further expand χDL with logical operation queues and iteration via pattern matching. The combination of these new features allows encoding of chemical syntheses in generalized, reproducible, and parallelized digital workflows rather than opaque and entangled single-step operations. This is showcased by synthesizing chiral diarylprolinol catalysts and subsequently utilizing them in various synthetic transformations (13 separate automated runs affording 3 organocatalysts and 12 distinct enantioenriched products in 42-97% yield, up to > 99:1 er), including automated catalyst recycling and reuse.

Identifiers

PMID39592595
PMCPMC11599859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.